Biopharmaceutical Development Service by Drug Development Solutions
.jpg.ashx?maxwidth=140&maxheight=60&bgcolor=white&mode=pad)
Status:
Reviewer
Member since: 2016
Organization: ICON plc on behalf of VHsquared
-
- Ease of use
- After sales service
- Value for money
Excellent
Application Area: PK and IG analysis in human matrices
"Quality, communication, punctuality and flexibility were all excellent."
Review date: 18 Nov 2016 | Biopharmaceutical Development Service
Our capabilities and experience cover recombinant proteins, vaccines, blood products, monoclonal antibodies, oligonucleotides, gene therapy products and more.
Development and validation of bioanalytical assays to support your biopharmaceutical development programme, whether it be Pharmacokinetic (PK), Anti-Drug-Antibody (ADA), Neutralising Antibodies (nAbs) or Pharmacodynamic (PD) is core to our business.
Our bioanalytical services for biopharmaceuticals include:
- New method development
- Method validation (GLP, GCP or non-regulated)
- Sample analysis to support discovery, preclinical and clinical programmes
- Macromolecule quantification and characterisation to support biopharmaceutical development and manufacture.
Experienced, qualified staff and investment in the latest technologies allow us to provide high quality bioanalytical services for biopharmaceuticals in support of all stages of your development.
Product Overview
Biopharmaceutical Development Service
Manufacturer Drug Development Solutions | Available Worldwide
5.0 / 5.0 | 1 reviews
.jpg.ashx?width=100&height=100&bgcolor=white)
